Transforming growth factor-beta signalling in brain disorders.
about
Candesartan, an angiotensin II AT₁-receptor blocker and PPAR-γ agonist, reduces lesion volume and improves motor and memory function after traumatic brain injury in mice.Common variants conferring risk of schizophrenia: a pathway analysis of GWAS data.Astrocytic transforming growth factor-beta signaling reduces subacute neuroinflammation after stroke in miceMolecular profiles of pyramidal neurons in the superior temporal cortex in schizophreniaTransforming growth factor-β1 induces matrix metalloproteinase-9 and cell migration in astrocytes: roles of ROS-dependent ERK- and JNK-NF-κB pathways.Strain rate-dependent induction of reactive astrogliosis and cell death in three-dimensional neuronal-astrocytic co-cultures.HIV-1 neuropathogenesis: glial mechanisms revealed through substance abuseProtection of TGF-β1 against neuroinflammation and neurodegeneration in Aβ1-42-induced Alzheimer's disease model rats.Molecular actions and therapeutic potential of lithium in preclinical and clinical studies of CNS disordersMultipotent mesenchymal stromal cells increase tPA expression and concomitantly decrease PAI-1 expression in astrocytes through the sonic hedgehog signaling pathway after stroke (in vitro study).Extracellular matrix abnormalities in schizophreniaTransforming growth factor β1-induced astrocyte migration is mediated in part by activating 5-lipoxygenase and cysteinyl leukotriene receptor 1.Lithium inhibits Smad3/4 transactivation via increased CREB activity induced by enhanced PKA and AKT signaling.Blood-brain barrier breakdown-inducing astrocytic transformation: novel targets for the prevention of epilepsy.Heterogeneity of microglial activation in the innate immune response in the brain.Early defect of transforming growth factor β1 formation in Huntington's disease.Crosstalk between cerebral endothelium and oligodendrocyte.Alteration of immune markers in a group of melancholic depressed patients and their response to electroconvulsive therapy.Microglia preconditioned by oxygen-glucose deprivation promote functional recovery in ischemic rats.Astrocytes in the aging brain express characteristics of senescence-associated secretory phenotype.Protein microarray analysis identifies key cytokines associated with malignant middle cerebral artery infarction.Transcriptomic profiling of astrocytes treated with the Rho kinase inhibitor fasudil reveals cytoskeletal and pro-survival responses.A key role for TGF-β1 in hippocampal synaptic plasticity and memory.Association of the functional SNP rs2275294 in ZNF512B with risk of amyotrophic lateral sclerosis and Parkinson's disease in Han Chinese.Estrogen and tamoxifen reverse manganese-induced glutamate transporter impairment in astrocytes.Glial metabotropic glutamate receptor-4 increases maturation and survival of oligodendrocytes.Common mechanisms in neurodegeneration and neuroinflammation: a BrainNet Europe gene expression microarray study.Topical Ocular Delivery of TGF-β1 to the Back of the Eye: Implications in Age-Related Neurodegenerative Diseases.Microglia and Monocytes/Macrophages Polarization Reveal Novel Therapeutic Mechanism against Stroke.Transforming growth factor-beta in the brain is activated by exercise and increases mobilization of fat-related energy substrates in rats.Examination of glucose transporter-1, transforming growth factor-β and neuroglobin immunoreactivity in the orbitofrontal cortex in late-life depression.TGF-β1 Neuroprotection via Inhibition of Microglial Activation in a Rat Model of Parkinson's Disease.Neural stem cell therapy for subacute and chronic ischemic stroke.Effects of Acute Confinement Stress-induced Hypothalamic-Pituitary Adrenal Axis Activation and Concomitant Peripheral and Central Transforming Growth Factor-β1 Measures in Nonhuman Primates
P2860
Q30528431-0E053C3A-2A59-468F-BB72-B8482C77750CQ33640930-64CA6A30-9D55-4A84-9587-03A48D20AF72Q33769818-EDDD5660-43A2-47B4-9339-4D0637B795C5Q34336202-A914FF14-B0B1-4858-B114-31AE614778FBQ34408250-3761E684-52D0-4FB0-9515-5A808D3C4B2AQ34635480-11CA7C76-EF9D-450F-84A1-8060CCC645A4Q35009465-AE149588-E50D-4FBF-8BFE-AE18F4DFE9D0Q35058396-6300B296-BAF4-4838-9594-14CB6449D8B1Q35197096-DDA44313-FA82-4D2B-BD7A-6854BDC88F17Q35534160-D21AEE9C-6F8D-453A-9F8D-697C5D9AA398Q35603175-68076D05-DFFB-4862-9F58-733C6F8043FDQ36164138-7A18FF90-9148-4623-9CE3-E60DB202184DQ36513464-3015B710-6A1D-4D10-ACC0-A516FCBC91FFQ37442196-D2EF0E72-81C9-4F21-B751-C527BAEF7191Q37572598-8E369DF8-EEE4-4483-B734-74C785C0C0C4Q37580232-BAD35673-25B2-49AA-882E-378F750977FAQ37620563-43249392-DC0C-484B-9D6B-1783AFA189E2Q37623631-B51DE2C5-753D-4361-B979-5AA36EB4DDBBQ37640315-85B1B39F-DB00-4940-B0C5-BA46D95FA3F4Q37886047-7AF90944-2FB1-4BEF-A1BD-ADF3D6C7149BQ38429567-E5398C9A-07B6-491F-99E3-349A56DC3C4BQ38502206-517C2B28-6824-4AF7-9B99-DC6F3282132DQ40852368-2C131789-AEEB-46CD-A80F-6EB34ADF1524Q41447031-63391D96-63BD-40C3-87D0-6615BCA3EFE9Q41846007-94C12514-0595-4DC7-9A98-DEB06F70A25AQ42178042-C086CA3F-EA11-4E21-A815-477235202BF4Q42677054-0751854E-F343-4865-ADCF-19E88B120CB2Q43864907-BB3F9EB1-1F5B-4613-81E2-2B4DFF2C5C87Q47106944-1F4D5DF3-F172-4A07-8172-23A936BC0015Q48271260-9303228A-6983-426F-A568-15D7A9DD1F8CQ48930350-F3A88207-DB20-4849-887C-3A53E1B9A35CQ53343059-C959DB63-5104-4B54-96E3-A8465D88F95AQ55344637-92CF618F-21CA-4BE2-9DA8-E26340441D9CQ58213874-C0CF1037-78A9-46EB-BB18-E9B06CCF7122
P2860
Transforming growth factor-beta signalling in brain disorders.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Transforming growth factor-beta signalling in brain disorders.
@ast
Transforming growth factor-beta signalling in brain disorders.
@en
type
label
Transforming growth factor-beta signalling in brain disorders.
@ast
Transforming growth factor-beta signalling in brain disorders.
@en
prefLabel
Transforming growth factor-beta signalling in brain disorders.
@ast
Transforming growth factor-beta signalling in brain disorders.
@en
P1476
Transforming growth factor-beta signalling in brain disorders.
@en
P304
P356
10.1016/J.CYTOGFR.2005.09.011
P577
2005-11-03T00:00:00Z